| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |